PHARMASEAL INTERNATIONAL LIMITEDActive

Company number 09993255Private limited companyIncorporated 2016

Key figures

£81,237-7.1%
Net assets 2025/26
-24.0%
Average annual change 2020/21–2025/26
-200 k0200 k400 k2020/212021/222022/232023/242024/252025/26

Like most small UK companies, PHARMASEAL INTERNATIONAL LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0250 k500 k750 k2020/212021/222022/232023/242024/252025/26
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Profit for the year-313,637-133,640-177,663——
Cash at bank and in hand254,449260,470463,584512,953289,577
Total assets443,175576,385546,823643,308408,831
Total liabilities————490,068
Net assets / total equity6,226-127,414229,58687,40081,237
Average number of employees87888

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: PHARMASEAL INTERNATIONAL LIMITED

Company

PHARMASEAL INTERNATIONAL LIMITED is a private limited company registered with Companies House under company number 09993255. It was incorporated on 8 Feb 2016. Its status is active. The registered office is in Nottingham (NG7). Its nature of business (SIC 2007) is information technology consultancy activities (62020).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files abridged accounts (unaudited). Net assets were £81,237, down 7.1% on the previous year. Cash at bank and in hand was £289,577. Total assets were £408,831 and total liabilities £490,068. The company had an average of 8 employees. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2027. The next confirmation statement is due by 22 Mar 2027.